awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33399656-257E15B9-2456-4E31-BD7B-C9E162ED7854
Q33399656-257E15B9-2456-4E31-BD7B-C9E162ED7854
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33399656-257E15B9-2456-4E31-BD7B-C9E162ED7854
A phase II trial of fixed-dose rate gemcitabine plus capecitabine in metastatic/advanced biliary tract cancer patients.
P2860
Q33399656-257E15B9-2456-4E31-BD7B-C9E162ED7854
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33399656-257E15B9-2456-4E31-BD7B-C9E162ED7854
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9aa6bfa7a661a3877dda87219a770f28c4a4d464
P2860
Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue.